Ortoma AB

Falkenbergsgatan 3, 412 85 Gothenburg, Sweden  All Sweden companies → Founded 2001
Specialty-Focused AI
Orthopedics
Surgical AI
Publicly Held — SEK 68 million (approximately USD 7.42 million)

Products

OTS Hip
Ortoma AB
Surgical AI
Ortoma Treatment Solution (OTS) Hip is an FDA-cleared, AI-based orthopedic surgical platform for preoperative planning, intraoperative navigation, and postoperative follow-up in total hip arthroplasty (THA).

See all 1 product →

About Ortoma AB

Ortoma AB is a Swedish medical technology company specializing in advanced surgical systems for orthopedic and joint implant procedures. Their core offering, the Ortoma Treatment Solution (OTS), is an integrated, AI-based digital platform designed to enhance patient outcomes through comprehensive surgical planning, precise intra-operative navigation, post-operative verification, and follow-up. The system leverages 3D modeling and artificial intelligence to assist surgeons in accurately measuring and planning implant placement for hip, knee, and spinal surgeries.

For physicians, the OTS platform aims to streamline workflows and improve surgical accuracy, potentially leading to fewer complications and enhanced long-term implant survival rates. The Ortoma Plan software, a component of OTS, processes patient anatomy from CT or MRI images to create 3D visualizations, enabling optimized pre-operative planning and implant selection. During surgery, the Ortoma Guide provides real-time navigation, assisting surgeons in achieving optimal implant positioning. The system is designed for easy integration into existing surgical processes, thereby increasing efficiency in orthopedic procedures.

Ortoma’s technology has received marketing approval in Europe and the USA for hip replacement surgeries, and they are actively expanding their solutions to other joint and spinal procedures. Recent clinical evaluations, such as for OTS Hip in Japan, have demonstrated the product’s ability to meet high market demands and provide significant benefits to surgeons and patients.

Focus Areas

Orthopedic surgery joint implant surgery hip replacement knee replacement spinal surgery surgical planning intraoperative navigation AI-assisted surgery 3D modeling from 2D X-rays patient outcome optimization digital health

Business Intelligence

Key InvestorsEureka, Sedermera, GU Ventures, Tommy Hansson, Anders Hallberg, Coeli Wealth Management AB, Handelsbanken Liv Försäkring AB, Robert Hölscher
PartnershipsDePuy Synthes (Johnson & Johnson MedTech), Johnson & Johnson K.K.
AcquisitionsNone
TechnologyAI-based software platform, orthopedic digital, server-based integrated AI platform, intraoperative image-guided localization system, 3D modeling from CT scans and 2D X-rays, passive marker sensor system for tracking
FDA Clearances1 (OTS Hip) cleared products (estimated)

What Physicians Need to Know

AI-Assisted Surgical Planning
Ortoma's Treatment Solution (OTS) leverages optimized AI algorithms for highly accurate 3D pre-operative planning, assisting surgeons in implant selection and optimal positioning.
Intraoperative Navigation & Guidance
The OTS system, including Ortoma Guide, provides real-time assistance during surgery for precise implant placement, enhancing surgical accuracy and reducing complications.
3D Modeling from Medical Imaging
Enables surgeons to accurately measure and plan in 3D based on patient-specific medical imaging data (primarily CT, with X-ray as an optional input for planning and reference for OTS Hip).
Orthopedic Specializations
The OTS platform is designed for a range of orthopedic procedures, including hip replacement, knee replacement, and spinal surgery.
Patient Outcome Optimization
Aims to deliver improved surgical results, leading to better patient outcomes, fewer complications, reduced reoperations, and enhanced long-term implant survival.
Regulatory Approvals
The Ortoma Treatment Solution (OTS) has marketing approval in both Europe and the United States for hip replacement surgeries.
Physician Tip

Ortoma AB's OTS system offers physicians a powerful tool for enhancing orthopedic surgery. Its AI-assisted 3D planning significantly reduces pre-surgical planning time from weeks to minutes, allowing for more efficient and personalized patient care. The intraoperative guidance ensures highly accurate implant positioning, which is crucial for minimizing complications and improving long-term implant survival. The system's small footprint and cost-effectiveness, especially compared to traditional robotic systems, make advanced navigation technology more accessible without requiring extensive changes to existing surgical workflows or equipment. This translates to greater precision, streamlined operations, and ultimately, better results for patients undergoing hip, knee, and spinal procedures.

The Ortoma Treatment Solution (OTS) is designed for seamless integration into existing surgical processes and routines. It allows surgeons to utilize their current operating room equipment with only minor alterations, facilitating a comfortable transition to the technology. Ortoma also engages in partnerships, such as the exclusive distribution agreement with Johnson & Johnson K.K. in Japan for OTS Hip, indicating a strategy for broader market integration and accessibility.

Products by Ortoma AB

1 product in the directory

OTS Hip
Ortoma AB
Surgical AI
Ortoma Treatment Solution (OTS) Hip is an FDA-cleared, AI-based orthopedic surgical platform for preoperative planning, intraoperative navigation, and postoperative follow-up in total hip arthroplasty (THA).

What the Web Says

Ortoma AB is a Swedish company specializing in AI-based software platforms for orthopedic and joint implant surgeries, with a focus on improving surgical accuracy and patient outcomes. Their flagship product, Ortoma Treatment Solution (OTS) Hip, has received marketing approval in both Europe and the United States. The company is actively seeking commercialization partners globally and has engaged in agreements for development and distribution of customized versions of their OTS Hip system.

Overall: Positive

Strengths

  • AI-based software platform for improved surgical accuracy.
  • Aims for better patient outcomes, fewer complications, and reduced reoperations.
  • System can be easily integrated into existing surgical processes.
  • Marketing approval in both Europe and the United States for OTS Hip.
  • Strong interest in their new 3D modeling concept from 2D x-ray images.
  • Development of accessories to reduce surgery time and increase value.

Limitations

  • No specific product or employer reviews found on G2, Glassdoor, Capterra, or Reddit for Ortoma AB.
  • Limited publicly available information regarding employee experiences or detailed product user feedback.

Based on reviews from: ODT Magazine, accessdata.fda.gov, PitchBook, Cision News

Last updated: 2026-07-19

Videos

News, demos, and interviews about Ortoma AB.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ortoma AB →

View all on YouTube

Press & Coverage

Biostock
Ortoma's rights issue oversubscribed - a total of SEK 68 million will be added to the company
Ortoma AB's rights issue was oversubscribed, resulting in a total of SEK 68 million being added to the company. This funding will support Ortoma's growth strategy and accelerate market penetration.
2026-04
MFN.se
Ortoma carries out a 100 per cent guaranteed rights issue of approximately SEK 52 million, and a directed new issue of shares of SEK 16 million
Ortoma AB announced a fully guaranteed rights issue of approximately SEK 52 million and a directed share issue of SEK 16 million, totaling SEK 68 million before transaction costs. This capital infusion is intended to provide financial flexibility for Ortoma's growth strategy and market acceleration.
2026-03
MedWorld Advisors
Ortoma AB Reaches Agreement with DePuy Synthes for its OTS (Ortoma Treatment Solutions) for Hip Replacement Therapy
Ortoma AB has reached a global development and distribution agreement with DePuy Synthes, part of Johnson & Johnson MedTech, for its Ortoma Treatment Solution (OTS) for hip replacement surgery. This collaboration aims to integrate DePuy Synthes' technology into Ortoma's customized OTS and expand its reach into key markets like the US and Europe.
2025-09
Becker's ASC Review
Dr. James Germano performs 1st hip replacement with ORTOMA system
Dr. James Germano performed the first AI-assisted total hip replacement surgery in the U.S. using the ORTOMA platform at Northwell's Long Island Jewish Valley Stream Hospital. The ORTOMA system provides intraoperative guidance, enhancing surgical precision and reducing operation time.
2025-07
Medicina (Kaunas)
Precision of Cup Positioning Using a Novel Computed Tomography Based Navigation System in Total Hip Arthroplasty
This peer-reviewed article evaluates the precision of cup positioning using Ortoma Treatment Solution (OTS) in total hip arthroplasty, highlighting the benefits of AI technology in improving surgical accuracy and patient outcomes.
2024-09
ODT Magazine
Ortoma's OTS Hip Gains 510(k) Clearance
Ortoma AB received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its OTS Hip system, an AI-powered technology platform designed to enhance precision, efficiency, and surgical outcomes in hip procedures.
2024-03
MedWorld Advisors
Ortoma to present groundbreaking 2D-3D technology for knee and hip joints at ISTA Congress 2023
Ortoma AB announced that two abstracts on its 2D-3D technology for knee and hip joints were accepted for presentation at the International Society for Technology in Arthroplasty (ISTA) congress. The presentations will focus on the company's AI-based software platform for converting X-ray images into 3D models.
2023-07
Semcon
AI-based software supports efficient healthcare
Semcon is collaborating with Ortoma to support the development of its AI-based operation system, Ortoma Treatment Solution (OTS), which enhances quality and streamlines procedures for hip, knee, and back surgery.
2022-01

Frequently Asked Questions

Ortoma AB's core product is the Ortoma Treatment Solution (OTS), an AI-assisted digital platform for orthopedic surgery. It is designed for planning and positioning implants in hip, knee, and spinal surgeries, with specific modules like OTS Hip Plan and OTS Hip Guide, and OTS Spine Plan.
Ortoma's OTS platform uses AI to assist surgeons in accurately measuring, planning 3D surgery, and optimally positioning joint implants. The system includes Ortoma Plan for preoperative 3D planning and Ortoma Guide for intraoperative navigation, aiming for better patient outcomes, fewer complications, and improved long-term implant survival rates.
Ortoma AB's OTS Hip system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing it to be marketed in the United States. The company also holds CE Mark approval for its hip and spine modules in Europe and JP certification for its hip implant planning module in Japan.
Ortoma AB has established significant strategic partnerships, notably with Johnson & Johnson K.K. for exclusive distribution rights of OTS Hip in Japan. They also have a development and distribution agreement with DePuy Synthes, part of Johnson & Johnson MedTech, for a customized OTS solution for hip replacement surgery, aiming for global market establishment.
The Ortoma Treatment Solution is designed for easy integration into existing surgical processes and routines, enhancing efficiency without significant workflow deviation. As a digital, server-based AI platform, it processes medical imaging data in DICOM format for preoperative planning and intraoperative guidance.
Ortoma AB is a publicly traded company listed on the Spotlight Stock Market in Sweden and Nasdaq Stockholm. While the company has reported revenue, it has also shown net losses in recent fiscal years, and its employee count is typically between 15 and 50.
Ortoma has developed and presented a proof-of-concept solution for converting 2D X-ray images into 3D models. This innovative technology aims to further enhance preoperative planning capabilities within their Ortoma Treatment Solution platform.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.